Close Menu

Merger Madness

As everyone is busy filling out their March Madness Brackets (and hoping that Duke loses), the Health Blog at the Wall Street Journal has come up with a bracket of their own, seeding pharmas against one another. Some of the results are already in -- Pfizer's taken down Wyeth and Roche's beaten Genentech -- but the winner of the "merger mania" isn't yet clear.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.